U.S. Magistrate Judge Joseph Dickson. Photo: Carmen Natale/ALM
Plaintiffs in multidistrict litigation claiming Allergan breast implants put them at risk of developing lymphoma may not proceed anonymously, a federal judge in Newark ruled Monday.
Most of the plaintiffs—73 out of 102—filed using initials or pseudonyms, Allergan said. But they failed to demonstrate the fear of “severe harm” needed to justify anonymity, U.S. Magistrate Judge Joseph Dickson ruled.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
